A novel approach of arteriovenous fistula formation in cultivation of an arm vein for use in infrainguinal surgical bypass grafting  by Rohrer, Rebecca M. et al.
From
G
Su
*Per
Lo
Auth
Rep
T
(e
The
to
an
2352
Cop
So
BY
4.
http
184A novel approach of arteriovenous ﬁstula formation
in cultivation of an arm vein for use in infrainguinal
surgical bypass grafting
Rebecca M. Rohrer, MSc,a Alexa H. Templeton, MRCS,b Eric S. Chemla, FRCS,b Marjan Jahangiri, FRCS,c
and Stephen A. Black, MD, FRCS (Ed),b,* London, United Kingdom
Autologous vein is preferable for use in lower limb arterial bypass rather than synthetic graft material. Suitable vein for
grafting is often limited, particularly in patients who have had previous cardiac bypass grafting or varicose veins surgery.
This case report describes the use of arteriovenous ﬁstula formation to cultivate an arm vein of a suitable diameter for use
in femorotibial bypassing. (J Vasc Surg Cases 2015;1:184-6.)Autologous vein is preferable for use in lower limb arte-
rial bypass rather than synthetic graft material. Suitable vein
for grafting is often limited, particularly in patients who
have had previous cardiac bypass grafting or varicose veins
surgery. We describe a patient in whom we formed an arte-
riovenous ﬁstula (AVF) to cultivate an arm vein of a suit-
able diameter for use in femorotibial bypassing. The
patient provided informed consent to publish this case
report.
CASE REPORT
A 70-year-old woman presented to the vascular outpatient
clinic with symptoms of left lower limb rest pain and nonhealing
ulcers with recurrent infections. Her medical history included hy-
pertension, hypercholesterolemia, myocardial infarction, and
smoking. She had previously undergone stripping of the left great
saphenous vein (GSV) and avulsions.
As part of the initial workup, a computed tomography angio-
gram showed occlusion of the left superﬁcial femoral artery at the
level of the adductor canal and knee popliteal disease, with collat-
erals ﬁlling via the profunda. The angiogram conﬁrmed that
although there was arterial disease, the anterior tibial artery still
provided in-line perfusion to the pedal circulation, making it the
only suitable target for surgery. A femorotibial bypass was subse-
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After a coronary angiogram, triple-vessel coronary artery bypass
grafting and tissue aortic valve replacement were performed. Har-
vested right GSV was used after the radial artery was deemed
unsuitable.
On review after cardiac optimization, she had ongoing lower
leg bilateral ulcers, lower limb rest pain, and further infections.
Vein mapping showed only small-caliber vessels in the upper limbs
and no usable residual veins in the lower limbs.
A multidisciplinary discussion concluded that this patient
would be at a high risk of infection should synthetic graft be
used. Interventional radiology successfully performed angioplasty
of the popliteal and anterior tibial artery through retrograde dorsa-
lis pedis access; however, attempts to reopen the superﬁcial femoral
artery were unsuccessful. A further attempt with a subintimal
approach was also ineffective.
With limited options available, it was suggested that bilateral
radiocephalic ﬁstulae could be used to improve the caliber of the
arm veins. Bilateral AVF formation was performed under local
anesthetic. Duplex scanning 32 days postoperatively showed an
increase in diameters of the veins by up to 6 mm: the cephalic
vein diameters increased from 2 mm bilaterally to 4 to 8 mm below
the elbow and to 3 to 4 mm above the elbow, and the basilic vein
increased from 2.5 to 5 mm above the elbow. Performing a fem-
oroanterior tibial bypass using arm vein in addition to common
femoral endarterectomy was now possible.
Despite a greater increase in diameter of the cephalic veins, the
basilic veins were also used due to the uniform increase in diameter
and better ﬂow. The entire left cephalic and basilic veins were har-
vested and spliced (each segment reversed appropriately), thus
creating a graft of sufﬁcient length to reach the intended target
vessel. A completion angiogram showed good ﬂow in the graft,
with a palpable dorsalis pedis pulse.
After a prolonged hypotensive period on the intensive care unit,
the dorsalis pedis pulse was no longer be audible onDoppler. On re-
turn to the operating theater, a graft embolectomy was performed
(early graft thrombosis being likely due to the periodof sustainedhy-
potension). The vein graft was then taken down, respliced, and
retunnelled. A completion angiogram showed good ﬂow within
the graft. The patient was discharged on day 16 postoperatively
because of an ongoing physiotherapy requirement.
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tion over the left medial malleolus ulcer, with a decrease in diam-
eter of w50%. In addition, the patient was mobilizing well, with
relief of her rest pain. Unfortunately, 6 months postoperatively
and after loss to follow-up, the patient presented with graft occlu-
sion, manifest as a claudication distance of 90 m.
DISCUSSION
Ipsilateral GSV remains the conduit of choice for
infrainguinal bypass due to its length and superior patency
rates.1,2 Autologous saphenous veins have reported sec-
ondary patency rates ranging from 86% to 93%3,4 at 3 years
and from 74.4% to 86%3,5 at 5 years.
GSV availability is often limited due to previous cardiac
bypass grafting, varicose vein treatment, or concurrent
lower limb deep vein thrombosis.6 Other conduit options
for femoropopliteal revascularization include arm vein,
autologous composite vein, or prosthetic grafts.
Autologous arm veins have secondary patency rates of
70.3% at 3 years and 57.5% at 5 years.7 Secondary patency
rates for human umbilical vein are 29% at 3 years8 and 57%
to 76% at 5 years.9,10 Arterial cadaveric allografts have 3-
year secondary patency rates of 42.1% compared with
25.9% at 5 years.11 The 1-year secondary patency rate for
cryopreserved vein allografts from cadavers is 42%.12 Use
of cadaveric grafts is further complicated by their high price
and reduced length, thus limiting their applicability for
lower limb bypass.
A Cochrane review13 concluded that autologous vein
grafts achieved improved patency compared with synthetic
materials for above-knee bypasses but the patency of pros-
thetic grafts is variable. Secondary patency rates for polyte-
traﬂuoroethylene are between 54% and 75% at 3 years14,15
and between 36% and 84.1% at 5 years.16,17 Dacron
(DuPont, Wilmington, Del) has secondary patency ranging
from 53% to 81%14,15 at 3 years and from 47% to 83.8% at
5 years.16,17
The global increase in vein diameter by up to 3 mm in
this patient is consistent with those found in a prospective
cross-sectional study of hemodialysis patients.18 In those
with a distal radiocephalic AVF, mean diameter of the
vein was 2.05 mm compared with 3 mm in an antecubital
AVF. In bypass studies, autogenous composite and GSV
diameter criteria included a minimum diameter of 3.5 to
4 mm.2,6 Human umbilical vein grafts used a diameter of
5 or 6 mm,10 in contrast to 6 or 8 mm for Dacron or
polytetraﬂuoroethylene.15,16
Prosthetic graft infection is a consideration. Siracuse
et al19 identiﬁed a graft infection rate of 3.8% at 27 months
of follow-up associated with a major lower extremity ampu-
tation hazard ratio of 9.8. No signiﬁcant difference was
found among prosthetic graft materials, although redo
bypass, female gender, and active infection at the time of
bypass were all associated with a higher risk.
Use of autologous GSV as a graft was prevented in this
patient due to prior coronary artery bypass grafting and
treatment of varicosities. In addition, the presence of ulcers
raised concerns regarding infection risk if synthetic graftswere used, although the extent of infection risk remains
unclear. The multidisciplinary team therefore adopted a
novel management approach. Despite occlusion of the
graft 6 months postoperatively, this innovative procedure
indicates technical feasibility in a patient whose ﬁrst-line
treatment options were extremely limited.
The use of AVF formation for means of arm vein culti-
vation represents a novel approach for overcoming this
problem. Arterialization of the veins provided a bypass
graft of sufﬁcient length and diameter and created a vessel
that was easier to handle intraoperatively. In addition, the
patient was provided with good symptomatic relief. The
creation of bilateral AVFs provides a future option for
revascularization of the right lower limb by using vein
from the left AVF. We believe this option should be
considered only when prosthetic or other allograft options
are not available. There are no data currently on the
optimal caliber that can be used from an AVF, with the
theoretical risk that use of too large a caliber might lead
to occlusion from a mural thrombus. We also believe that
this is an inferior option for those with foot ulcers, because
a delay in revascularization for >1 month, which is the time
taken for the vein caliber to augment after AVF, has been
suggested to risk limb loss.20
Associated data on outcome and patency rates for this
approach are lacking and a necessary focus for long-term
follow up. In addition, successful implementation, as with
this patient, relies heavily on multidisciplinary and interspe-
cialty cooperation.
CONCLUSIONS
This case represents the use of a novel technique to
overcome a common vascular scenario. It provides a
further option to the use of prosthetic grafts in patients
with insubstantial or absent vein for lower limb bypass.
This is in the absence of other case reports to adequately
assess patency rates and long-term outcomes and in light
of limitations of the study.REFERENCES
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